Used as a key intermediate in the synthesis of protease inhibitors, particularly in the development of antiviral drugs such as those targeting HIV and hepatitis C virus. Its chiral structure enables selective interactions with enzyme active sites, making it valuable in creating highly specific pharmaceutical agents. Commonly employed in asymmetric synthesis to introduce stereochemical control in complex molecule assembly. Also utilized in research settings for designing enzyme inhibitors with improved binding affinity and metabolic stability.